We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vertex Pharmaceuticals Inc | NASDAQ:VRTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-0.91 | -0.22% | 404.00 | 401.22 | 406.40 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
406.825 | 399.29 | 404.50 | 806,474 | 00:55:27 |
Date | Time | Source | Headline |
---|---|---|---|
16/1/2024 | 20:07 | DJN | Vertex Pharmaceuticals Says FDA Approved Casgevy for TDT Patients |
13/12/2023 | 17:48 | DJN | Editas Medicine Strikes License Deal With Vertex Pharmaceuticals -- Update |
13/12/2023 | 15:49 | DJN | Vertex Pharmaceuticals Up Over 8%, on Track for Record High Close -- Data.. |
13/12/2023 | 14:49 | DJN | Editas Medicine Strikes License Deal With Vertex Pharmaceuticals |
08/12/2023 | 21:11 | DJN | Bluebird Bio Shares Slide 41% on Black-Box Label, Higher Price for.. |
08/12/2023 | 16:46 | DJN | CRISPR, Vertex Get FDA OK of Casgevy Gene Therapy in Sickle-Cell Disease |
29/11/2023 | 19:55 | DJN | Vertex Pharmaceuticals' Kalydeco Gets Expanded Use Authorization from.. |
24/11/2023 | 15:06 | DJN | Vertex Pharmaceuticals Gets Regulatory OK to Extend Use to More Patients in.. |
23/11/2023 | 14:54 | DJN | Vertex Pharmaceuticals Cystic Fibrosis Treatment Approved for Young.. |
15/11/2023 | 19:32 | DJN | Vertex Pharmaceuticals Worst Performer in the S&P 500 and the Nasdaq 100 So.. |
1 Year Vertex Pharmaceuticals Chart |
Intraday Vertex Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions